110
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome

, , , , , , , , , , , , & show all
Pages 113-118 | Published online: 10 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pietro Gareri, Alberto Castagna, Antonino Maria Cotroneo, Salvatore Putignano, Giovambattista De Sarro & Amalia Cecilia Bruni. (2015) The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives. Clinical Interventions in Aging 10, pages 1421-1429.
Read now
Antonino Maria Cotroneo, Alberto Castagna, Salvatore Putignano, Roberto Lacava, Fausto Fantò, Francesco Monteleone, Filomena Rocca, Alba Malara & Pietro Gareri. (2013) Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clinical Interventions in Aging 8, pages 131-137.
Read now

Articles from other publishers (11)

Pedro E Bermejo, Rodolfo Dorado & María Ascensión Zea-Sevilla. (2023) Role of Citicoline in Patients With Mild Cognitive Impairment. Neuroscience Insights 18, pages 263310552311524.
Crossref
Pietro Gareri, Nicola Veronese & Antonino Maria Cotroneo. (2022) An Overview of Combination Treatment with Citicoline in Dementia. Reviews on Recent Clinical Trials 17:1, pages 4-8.
Crossref
Pietro Gareri, Antonino Maria Cotroneo, Giuseppe Orsitto & Salvatore Putignano. (2020) The CITIMEM study: A pilot study. Optimizing pharmacological treatment in dementia. Archives of Gerontology and Geriatrics 89, pages 104073.
Crossref
Xiguang Feng, Yi Chen, Min Zhang, Miaojie Fang, Cuimei Xiao & Junzhu Chen. (2020) Protective effect of citicoline on random flap survival in a rat mode. International Immunopharmacology 83, pages 106448.
Crossref
Azadeh AminzadehAyda Salarinejad. (2019) Citicoline protects against lead-induced oxidative injury in neuronal PC12 cells. Biochemistry and Cell Biology 97:6, pages 715-721.
Crossref
Patricia Bogdanov, Joel Sampedro, Cristina Solà-Adell, Olga Simó-Servat, Carla Russo, Luisa Varela-Sende, Rafael Simó & Cristina Hernández. (2018) Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration. International Journal of Molecular Sciences 19:8, pages 2458.
Crossref
Ahmed O Abdel-Zaher, Mostafa M Hamdy, Mahran S Abdel-Rahman & Doaa H Abd El-hamid. (2016) Protective effect of citicoline against aluminum-induced cognitive impairments in rats. Toxicology and Industrial Health 33:4, pages 308-317.
Crossref
Pietro Gareri, Alberto Castagna, Antonino Maria Cotroneo, Daria Putignano, Raffaele Conforti, Francesco Santamaria, Saverio Marino & Salvatore Putignano. (2017) The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer’s Disease Study. Journal of Alzheimer's Disease 56:2, pages 557-565.
Crossref
Alberto Castagna, Antonino Maria Cotroneo, Giovanni Ruotolo & Pietro Gareri. (2016) The CITIRIVAD Study: CITIcoline plus RIVAstigmine in Elderly Patients Affected with Dementia Study. Clinical Drug Investigation 36:12, pages 1059-1065.
Crossref
Andrea Matteucci, Monica Varano, Lucia Gaddini, Cinzia Mallozzi, Marika Villa, Flavia Pricci & Fiorella Malchiodi-Albedi. (2014) Neuroprotective Effects of Citicoline in in Vitro Models of Retinal Neurodegeneration. International Journal of Molecular Sciences 15:4, pages 6286-6297.
Crossref
Pawel Grieb. (2014) Neuroprotective Properties of Citicoline: Facts, Doubts and Unresolved Issues. CNS Drugs 28:3, pages 185-193.
Crossref